Summary - ANIP - NASDAQ - Weiss Ratings

D

ANI Pharmaceuticals, Inc. ANIP

$58.03 $1.061.86%

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

--

52-Week Range

$48.20 - $70.81

P/E (TTM)

--

EPS (TTM)

My Lists My Alerts

Report

Biotechnology Health Care Pharmaceutical

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

--

Headlines

ANI Pharmaceuticals (ANIP, $58.03) Moving Average Convergence Divergence (MACD) Histogram turned positive on December 9, 2024

12/10/2024 - Tickeron - Stocks

Zurcher Kantonalbank Zurich Cantonalbank Has $177,000 Stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)

12/9/2024 - Ticker Report

Charles Schwab Investment Management Inc. Increases Stock Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)

12/8/2024 - Ticker Report

Are Medical Stocks Lagging Adagene (ADAG) This Year?

12/6/2024 - Zacks Investment Research

ANI Pharmaceuticals (ANIP, $56.86) Moving Average Convergence Divergence (MACD) Histogram turned negative on December 4, 2024

12/5/2024 - Tickeron - Stocks

Brokerages Set ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Target Price at $77.33

12/5/2024 - Ticker Report

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

12/2/2024 - Zacks Investment Research

Martingale Asset Management L P Grows Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)

12/1/2024 - MarketBeat

Bank of Montreal Can Makes New $13.04 Million Investment in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)

12/1/2024 - MarketBeat

ANI Pharmaceuticals (NASDAQ:ANIP) Stock Price Down 2.9% and#8211; Should You Sell?

12/1/2024 - Ticker Report

ANI Pharmaceuticals (NASDAQ:ANIP) Shares Down 2.9% - Here's What Happened

11/30/2024 - MarketBeat

Connor Clark and#038; Lunn Investment Management Ltd. Has $804,000 Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)

11/29/2024 - Ticker Report

Insider Selling: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) CEO Sells 33,481 Shares of Stock

11/28/2024 - MarketBeat

ANI Pharmaceuticals (ANIP, $59.39) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 27, 2024

11/28/2024 - Tickeron - Stocks

Here's Why Retaining Cigna Stock is a Smart Move for Investors Now

11/27/2024 - Zacks Investment Research

Rubric Capital Management LP Lowers Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)

11/27/2024 - MarketBeat

ANI Pharmaceuticals (ANIP, $57.86) price exceeded its 50-day Moving Average on November 26, 2024

11/27/2024 - Tickeron - Stocks

ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference

11/26/2024 - GuruFocus

ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference

11/26/2024 - Globe Newswire

Does ANI (ANIP) Have the Potential to Rally 31.31% as Wall Street Analysts Expect?

11/26/2024 - Zacks Investment Research

Eagle Asset Management Inc. Purchases New Shares in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)

11/26/2024 - MarketBeat

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Acquired by Pacer Advisors Inc.

11/23/2024 - MarketBeat

Compelling Reasons to Hold on to Ensign Group Stock Now

11/21/2024 - Zacks Investment Research

ANI (ANIP) Upgraded to Buy: What Does It Mean for the Stock?

11/20/2024 - Zacks Investment Research

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

11/20/2024 - Zacks Investment Research

Income Statement

Total Revenue (TTM)

EBITDA (TTM)

EBIT (TTM)

Net Income (TTM)

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

Cash from Investing (TTM)

Cash from Financing (TTM)

Net Change in Cash (TTM)

Filings

Filing Date

Friday, November 8, 2024

Period Date

Monday, September 30, 2024

Next Filing

Week of Feb 24 and 28 (est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

5-Year Total Return

52-week Low

Dec 08, 2023 - $48.20

52-week High

Mar 25, 2024 - $70.81

Valuation

Market Cap

$1.11B - Small Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

--

Dividend Per Share (TTM)

--

Corporate Info

Website

www.anipharmaceuticals.com

Phone Number

218 634 3500

Address

210 Main Street West
Baudette, MN 56623

Country

Year Founded

Business Description

Sector

Industry

Pharmaceuticals, Biotechnology and Life Sciences

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company... more